Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
1 Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill, USA.
2 Department of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill, USA.
3 Department of Medicine, School of Medicine, Department of Health Behavior, Gillings Global School of Public Health, University of North Carolina at Chapel Hill, USA.